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Abstract: Recurrent aphthous stomatitis (RAS) is an inflammatory condition of unknown etiology. The exact role of the leukocytes
in the pathogenesis of RAS is not known. The aim of this study was to evaluate the status of the oxidative system in neutophils of
RAS patients.
A total of 26 patients and 22 sex and age matched healthy control subjects were analyzed by measuring intracellular
oxidant/antioxidant enzymes and related parameters; myeloperoxidase (MPO), xanthine oxidase (XO), catalase (CAT), superoxide
dismutase (SOD), adenosine deaminase (AD), malondialdehyde (MDA) and nitric oxide (NO).
Statistically significant increases in the activities of SOD, CAT and levels of MDA, NO were detected in the neutrophils of patients.
There was no significant difference in MPO, AD and XO activities of neutrophils.
Although the functions of neutrophils were normal, there may be an oxidative stress affecting neutrophils in RAS.
Key Words: Recurrent aphtous stomatitis, neutrophils, oxidative system

Introduction
Recurrent aphthous stomatitis (RAS) is one of the
most common oral mucosal diseases. It has three clinical
variants, of a minor, major and herpetiform RAS. Minor
RAS is characterized by painful, round or oval shallow
ulcers, usually less than 5 mm in diameter. A gray-white
pseudomembrane is surrounded by a thin erythematous
halo. Minor RAS is the most common variant and
constitutes about 80% of RAS cases (1, 2). Major RAS is
an uncommon and severe form with ulcers exceeding 1
cm in diameter. Ulcers may persist for up to 6 weeks or
more and often heal with scarring (1-3). Herpetiform
RAS is the least common type. It is characterized by
multiple crops of small, painful ulcers of the oral cavity.
Furthermore 100 ulcers may be present at a given time
and produce large ulcers with irregular border (1, 3).
Although RAS has been the subject of considerable
studies, the etiology and pathogenesis of the disease have

not yet been completely explained (1, 2, 4, 5). Local and
systemic conditions, genetic, immunological and
infectious factors have been identified as potential
etiological agents. The free radical metabolism in the
erythrocyte and serum of RAS patients has been
investigated in two recent studies (6, 7). Also there are a
few studies showing the active role of white blood cells in
RAS pathogenesis (8, 9). Although the chemotactic
function of neutrophils is normal in RAS (10), their
marked concentrations at the ulcer area suggest that they
may play an active role in the pathogenesis. However, the
exact role of neutrophils in the pathogenesis or healing of
RAS is still unknown.
The aim of our study was to evaluate the change in
the oxidative system in neutrophils of RAS patients by
measuring intracellular oxidant/antioxidant enzymes and
related parameters; myeloperoxidase (MPO), xanthine
oxidase (XO), catalase (CAT), superoxide dismutase
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(SOD), adenosine deaminase (AD), malondialdehyde
(MDA) and nitric oxide (NO).

reactions of TBA and MDA, the last product of fatty acid
peroxidation. Levels were expresed as nanomoles (nmol)
per gram protein.

Materials and Methods

XO activity determination: Xanthine oxidase activity
was assayed spectrophotometrically at 293 nm and 37°C
with xanthine as substrate (13). The formation of uric
acid from xanthine results in an increase in absorbency.
One unit of activity was defined as 1 µmol of uric acid
formed per minute at 37°C, pH 7.5, and expressed in
units per gram protein.

Subjects
The study was conducted at Zonguldak Karaelmas
University Medical Faculty, Departments of Dermatology
and Biochemistry. A total of 26 (14 male and 12 female)
patients with minor RAS which recurred not less than
four times a year, and had a history of at least one year,
were included in the study. The patients were otherwise
healthy. Also, they had not been under any systemic or
topical therapeutic regimen at least for the last 2 months.
All patients having RAS had more than one ulcer present
for not more than 48 h at the time of analysis. Twenty
two (12 male and 10 female) age and sex matched
healthy volunteers with no a history of RAS were selected
to form the control group.
The patients and controls with a history of smoking
and alcohol habits, systemic disorders, or who were
diagnosed to have Behçet’s disease according to the
diagnostic criteria of the International Behçet Committee
were excluded from the study.
Methods
Preparation of peripheral blood leukocytes
A total of 10 ml of venous blood was with drawn
from each patient after overnight fasting. Samples were
transferred into plastic tubes containing 20mg solid
EDTA for the separation of leukocytes by a dextran
sedimentation method. After sedimentation, the
remaining red cells in the leukocyte fraction were
removed by hypotonic shock using chilled water in
0.6mol/L KCl. This separation generally contained 90%
neutrophils, whereas the remainder of the cells consisted
of monocytes, lymphocytes and eosinophilis. Leukocytes
were lysed by repeated thawing and freezing after
addition of 0.2% Triton X. After this, supernatants were
examined by light microscopy and no leukocytes were
found (11).
MDA determination: The MDA level of neutrophils
was determined by Draper’s method. The levels were
measured as thiobarbituric acid reactive substance
(TBARS). The principle of the test was based on the
formation of a coloured complex at 532 nm with
maximum absorbance (12). This complex is a result of the
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NO determination: As NO measurement is very
difficult in biological specimens, tissue nitrite (NO2 ) and
nitrate (NO3-) were estimated as an index of NO
production. The method was based on the Griess reaction
(14). Samples were initially deproteinized with Somogyi
reagent. Total nitrite (nitrite+nitrate) was measured after
conversion of nitrate to nitrite by copporized cadmium
granules by a spectrophotometer at 545 nm (Ultraspec
Plus, Pharmacia LKB Biochrom Ltd, England). A standard
curve was established with a set of serial dilutions (10-810-3 mol/L) of sodium nitrite. Linear regression was done
by using the peak area from the nitrite standard. The
resulting equation was then used to calculate the
unknown sample concentrations. Results were expressed
as nmol per gram protein.
SOD activity determination:: Total (Cu-Zn and Mn)
SOD (EC 1.15.1.1) activity was determined according to
the method of Sun et al (15). The principle of the method
is based on the inhibition of NBT reduction by the
xanthine-xanthine oxidase system as a superoxide
generator. Activity was assessed in the ethanol phase of
the lyzate after 1.0 ml ethanol/chloroform mixture (5/3,
v/v) was added to the same volume of sample and
centrifuged. One unit of SOD was defined as the enzyme
amount causing a 50% inhibition in the NBT reduction
rate. SOD activity was also expressed as Units per
milligram protein (U/mg protein)
Adenosine deaminase activity determination: AD
activities were estimated spectrophotometrically by the
method of Giusti, which is based on the direct
measurements of the formation of ammonia, produced
when AD acts in excess of adenosine (16). Results were
expressed as units per gram protein (U/g protein).
CAT activity determination: CAT activity was
determined according to Aebi’s method (17). The
principle of the method is based on the determination of
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the rate constant (s-1, k) or the H2O2 decomposition rate
at 240 nm. Results were expressed as k (rate constant)
per gram protein
MPO activity determination: MPO (EC 1.11.1.7)
activity was determined using a 4-aminoantipyrine/phenol
solution as the substrate for MPO-mediated oxidation by
H2O2, and changes in absorbance at 510 nm (A510) were
recorded (9). One unit of MPO activity was defined as
that which degraded 1 µmol H2O2/min at 25˚C. Results
were presented as milli units per gram tissue protein.
Protein determination: Protein measurements were
made according to the method of Lowry et al (18). All
samples were assayed twice.
Statistics: All values were expressed as mean ±
standard deviation. SPSS for Windows 11.0 was used for
statistical analysis. Student’s t-test was used to estimate
the significance between parameters. The differences
were considered to be significant when the probability
was less than 0.05.

Results
The mean ± Sd age ranges of the patients and the
control group were 32.0 ± 11.3 and 33.0 ± 13.2 years,
respectively. There was no statistically significant
difference between the ages of the patients and controls.
The average test results of neutrophils are presented
in Table 1. A statistically significant increase in levels of
neutrophil MDA and NO were noted in the RAS group.
Also there were increased activities of CAT and SOD. No
significant difference was found in neutrophil MPO, XO,
and AD activities among the groups.

Table 1. Comparison of parameters of RAS and controls (Mean ±
Standard Deviation).

MDA* (nmol/g prot.)

RAS (n:26)

Controls (n:22)

47.74 ± 14.75

34.00 ± 10.23

SOD* (U/mg prot.)

1.72 ± 0.68

1.15 ± 0.41

CAT* (k/g prot.)

18.43 ± 6.68

12.70 ± 4.75

NO* (nmol/g prot.)

2.64 ± 1.25

1.69 ± 0.76

MPO (mU/g prot.)

32.33 ± 11.48

28.85 ± 10.44

AD (U/g prot.)

11.29 ± 8.55

9.56 ± 5.25

XO (U/g prot.)

3.21 ± 1.395

2.56 ± 0.75

* P < 0.01

Discussion
The etiology of RAS is still unknown, but it appears to
be related to an immune reaction to the oral mucosa
(19). It was also demonstrated that peripheral blood
neutrophils play an important role in tissue damage in
RAS (10). Although the chemotactic function of
neutrophils is normal in RAS, they are markedly
concentrated at the ulcer area (10). In a recent study, it
was (20) suggested that circulating PMNs were primed in
the active RAS, as well as in the remission stage of the
disease. They confirmed their hypothesis by measuring
the levels of high reactive oxygen species (ROS) in the
neutrophils. However, in previous studies, oxygen radical
production and phagocytic function of the neutrophils
have been found to be similar to that of the controls (8,
21). MPO levels are directly related to the phagocytic
activity of leukocytes. When there is bacterial or viral
antigen stimulus to the immune system, both the
chemotactic and phagocytic activities of leukocytes
increase. After phagocytosis, leukocytes produce large
amounts of ROS through the action of NADPH oxidase
and MPO (22). The normal levels of MPO in the
neutrophils in RAS cases are correlated with the previous
studies showing normal phagocytic activities of
leukocytes in RAS (8, 21).
Although there are a few studies on free radical
metabolism of erythrocytes and serum in RAS, to our
knowledge, the oxidant/antioxidant status in neutrophils
has not been studied up to now. (6, 7). In our study,
neutrophilic MDA levels have been found higher than the
control group. This result pointed out that there is a ROS
toxicity affecting the neutrophils. Cimen et al. also found
increased levels of MDA in serum and erythrocytes in RAS
patients, but they gave explanation no about source of the
oxitative stress. The source of ROS may be either
activation of phagocytic cells or increased activities of
ROS producing enzymes such as Xanthine oxidase and
NADPH oxidase. In our opinion, the source of oxidative
stress may be the NADPH oxidase of endothelial cells.
Healy et al. have showed that the expression of Vascular
cell adhesion molecule (VCAM-1) and E-selectin on blood
vessels in RAS are likely to be important in the
accumulation of inflammatory cells. (23, 24). VCAM-1
activates endothelial cell NADPH oxidase, which catalyzes
production of ROS. Increase of adhesion molecules and
ROS helps the extravasation of leukocytes (25). During
this period, increased ROS may affect the unsaturated
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fatty acids found in the membrane of the neutrophils and
cause their oxidation. This process may result in an
increase in the levels of lipid peroxidation end products as
MDA (26).
The cellular antioxidant defense system operates
through enzymatic and nonenzymatic components. CAT
and SOD are the necessary enzymes for an effective
defense against ROS. SOD accelerates the formation of
hydrogen peroxide (H2O 2) by using superoxide radicals.
CAT is the enzyme that accelerates the degradation of
unstable H2O2 to H2O and O2. Cimen et al. found nonsignificantly higher activities of SOD in plasma and
erythrocytes and significantly higher activity of CAT in
RAS patients (7). Also Gündüz et al. found higher but
non-significant erythrocyte activities of CAT and SOD (6).
Increased activities of SOD and CAT in our study shows
that the defense mechanisms of neutrophils were
activated against increased levels of ROS which may be
produced by non neutrophilic sources.
Nitric oxide is an important modulator of the
inflammatory cascade. In the acute and chronic
inflammatory disorders, NO has been shown to influence
many pathophysiological processes, such as VCAM-1
expression, leukocyte – endothelial interaction and
inflammation. Recent studies have suggested that NO
may modulate cytokine induced ECAM expression (27).
Since there is a leukocytic endothelial interaction and
extravasation of leukocytes in RAS, increased levels of NO
in neutrophils is the expected result. However, Gündüz et
al. also investigated serum levels of NO in RAS patients
and found no significant differences compared with the

controls. They concluded that NO did not play a primary
role in the inflammatory reaction observed in RAS.
Purine nucleotides are degraded by a pathway in
which AD and XO play role and uric acid is produced as an
end product. XO is a well known documented biologic
source of oxygen free radical and AD has been accepted
as an important enzyme in maturation and function of
leukocytes (28). Sogut et al. have found that AD and XO
activities are significantly increased in Behçet’s disease in
which antigens, such as bacteria, virus and heat shock
proteins induce tissue damage directly or by stimulating
the leukocytes (29, 30). Normal activities of both
enzymes in RAS may suggest that there is no proliferation
of neutrophils. Our findings correlate with the results of
Wray et al. They also found that there was no increase in
the number of neutrophils in RAS (21).
In conclusion: Neutrophils may be affected by vascular
adhesion molecules and endothelial ROS, and this effect
can be minimized by increasing antioxidant enzymes such
as SOD and CAT.
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